期刊文献+

糖化血红蛋白监测对冠心病合并糖尿病患者血糖控制的影响 被引量:10

Clinical Significance of HbA_(1c) Monitoring in Glycaemic Control in Diabetes Patients Complicated with Coronary Artery Disease
暂未订购
导出
摘要 目的探讨合并糖尿病的冠心病患者血糖控制状况的影响因素。方法连续入选符合本研究入选标准的406例冠心病合并糖尿病患者,通过电话随访完成相关调查问卷。所有患者随访至2009年9月—2010年7月。除近3个月内有明确记录者外,均门诊检测糖化血红蛋白(HbA1 c),并根据其结果将患者分为血糖控制达标组和未达标组。比较两组患者临床资料及出院后诊疗状况,分析影响血糖控制的因素。结果共320例患者完成随访,随访率78.8%,平均随访时间21.2个月。HbA1 c达标率为47.8%。血糖控制良好的相关因素包括:冠状动脉三支血管病变、规律运动、定期检测HbA1 c及了解血糖控制目标值。多因素分析显示,定期检测HbA1 c是改善患者血糖控制的最有效措施(OR=3.99)。结论合并糖尿病的冠心病患者血糖控制状况尚不理想,监测HbA1 c可有效改善血糖控制达标率,应引起临床医生的重视。 Objective To investigate the influencing factors of glycaemic control in diabetes patients with complicated coronary artery disease(CAD).Methods A total of 406 patients were consecutively enrolled.Questionnaires were completed via telephone interview and patients were followed from September,2009 to July 2010.HbA1c levels were examined and the subjects were divided into two groups accordingly:the group who had reached the standard of glycaemic control and elsewise.Clinical data and diagnosis-and-treat after discharge were compared between the two groups to analyze influencing factors of glycaemic control.Results The follow-up were completed in 320(78.8%) patients,with an average follow-up duration of 21.2 months.Rate of patients who reached the standard of glycaemic control was 47.8%.Correlated factors of better glycaemic control were:3-vessel lesion,regular exercises,regular HbA1c examinations,and knowledge of the aim of glycaemic control.Multi-factor logistic regression analysis showed that HbA1c monitoring was the most effective measure to improve the glycaemic control.Conclusion HbA1c monitoring is an effective measure to improve the glycaemic control and deserve the attention of clinicians.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第20期2251-2252,2256,共3页 Chinese General Practice
关键词 冠心病 糖尿病 血红蛋白A 糖基化 Coronary artery diease Diabetes mellitus Hemoglobin A glycosy lated
  • 相关文献

参考文献10

  • 1中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量:475
  • 2Kcreiakes DJ, Petersen JL, Batchelor WB, et al. Clinical and anglo- graphic outcomes in diabetic patients following single or muhivessel stent- ing in the COSTAR II randomized trial [J]. J Invasive Cardiol, 2008, 20 (7): 335-341.
  • 3Eeg - Olofsson K, Cederholm J, Nilsson PM, et al. New aspects of HbAlc as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR) [J]. J Intern Med, 2010, 268 (5) : 471 -482.
  • 4Reaven PD, Moritz TE, Schwenke DC, et al. Intensive glucose - low-ering therapy reduces cardiovascular disease events in veterans affairs di- abetes trial participants with lower calcified coronary atherosclerosis [J]. Diabetes, 2009, 58 (11): 2642-2648.
  • 5吕玉洁,张楠,孙飞,万钢,要立娜,马卫华,马淑贤,谷金慧,赵晔,金凤实,卜祥雷,鲁宗学,袁申元.北京崔各庄社区糖尿病患者糖化血红蛋白水平及其相关因素研究[J].中国全科医学,2010,13(10):1081-1083. 被引量:7
  • 6王群,幺伟,安秀英,李萍,刘晓亮.邢台市健康人群糖化血红蛋白参考区间的研究[J].中国全科医学,2009,12(22):2067-2068. 被引量:5
  • 7Landman GW, Van Hateren K J, Kleefstra N, et al. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC - 11 ) [ J ] Br J Gen Pract, 2010, 60 (572): 172 -175.
  • 8Stratton IM, Adler AI, Neff HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKP- DS 35 ) : prospective observational study [ J ]. BMJ, 2000, 321 (7258) : 405 -412.
  • 9Berry C, Noble S, Gr~goire JC. Glycaemic status influences the nature and severity of coronary artery disease [ J ]. Diabetologia, 2010, 53 (4) : 652 -658.
  • 10Stolker JM, Sun D, Conaway DG. Importance of measuring glycosy- lated hemoglobin in patients with myocardial infarction and known dia- betes mellitus [J]. Am J Cardiol, 2010, 105 (8) : 1090 -1094.

二级参考文献28

  • 1李淑翠,李淑芬.血小板参数及糖化血红蛋白测定在糖尿病微血管病变中的意义[J].中国误诊学杂志,2004,4(5):725-726. 被引量:8
  • 2姚印刚,毕珣,翟轶波,靳立忠.免疫比浊法检测糖化血红蛋白的应用评价[J].武警医学院学报,2005,14(4):274-275. 被引量:5
  • 3李素青,田玉华,朱敏,杨超元.中老年糖尿病流行病学调查方法探讨[J].实用老年医学,1996,10(4):175-176. 被引量:13
  • 4郑遵荣,赵冬敏,蔺慧敏.糖化血红蛋白测定的临床应用[J].中国城乡企业卫生,2006,21(5):39-40. 被引量:34
  • 5卫生部医政司.全国临床检验操作规程[M].3版.南京:东南大学出版社,2006:347.
  • 6金大鹏,袁申元,朱良湘.全科医师实用手册[M].4版.北京:人民卫生出版社,2009:252-261.
  • 7The Action to Control Cardiovascular Risk in Diabetes Study Group.Effects of Intensive Glucose Lowering in Type 2 Diabetes[J].N Engl J Med,2008,358:2545-2559.
  • 8American Diabetes Association.Standards of medical care in diabetes-2010D[J].Diabetes Care,2010,33(1):511-561.
  • 9Woerle HJ,Pimenta WP,Meyer C,et al.Diagnostic and therapeutic implications of relationships between fasting,2-hour postchallege plasma glucose and hemoglobin alc Values[J].Arch intern Med,2004,164 (15):1627-1632.
  • 10Khaw KT,Wareham N,Bingham S,et al.Association of HbA1c with cardiovascular disease and mortality in adults:the European prospective investigation into cancer in Norfolk[J].Ann Intern Med,2004,141 (5):413-420.

共引文献484

同被引文献77

引证文献10

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部